Pinsent Masons advises RPMI Railpen on formation of $700m joint venture
12 Mar 2018 | 09:41 am |
International law firm Pinsent Masons has advised RPMI Railpen on its $200m commitment to a joint venture with The Alaska Permanent Fund Corporation and the Public Institution for Social Security of Kuwait.
The innovative joint venture among asset owners, Capital Constellation, will invest in next generation private equity and alternative investment managers. Together, the joint venture partners will initially commit $700 million and Constellation is expected to deploy over $1.5 billion in investment capital over the next five years. Constellation will be advised by Wafra, a leading manager of private equity and alternative assets.
The Pinsent Masons team acting on the transaction was led by investment funds partners Ian Warner and David Young with investment funds senior associate Oliver Crowley, tax partner Eloise Walker and tax senior associate Jeremy Webster.
Commenting on the deal, Ian Warner said:
"The formation of Capital Constellation is a great success and exemplifies RPMI Railpen's innovative approach to investments. The ability of the Pinsent Masons team to deliver expert legal and commercial advice on this complex transaction is testament to the quality of our growing investment funds practice."
Kirkland & Ellis LLP advised Wafra and Sheppard Mullin acted for the Alaska Permanent Fund Corporation.
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland
Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.
Pinsent Masons advises on Four Seasons Care Homes portfolio migration
Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.
Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.
Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).
People who viewed this press release also viewed
Show me all press releasesPinsent Masons appointed to UK Government Trade Law Panel
Multinational law firm Pinsent Masons has been appointed to the UK Government's new Trade Law Panel in an international consortium with BakerHostetler in the USA, and Fasken in Canada, to advise on international trade law disputes.
Pinsent Masons advises on Sustainability Bond issued by Aster Group
Multinational law firm Pinsent Masons has advised the joint lead managers in relation to a £250m sustainability bond issued by Aster Group to develop new affordable homes.
Pinsent Masons advises GNA Biosolutions GmbH on Covid-19 rapid PCR test
Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]